Cargando…
Response to letter to the Editors—Safety of long-term denosumab therapy
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196008/ https://www.ncbi.nlm.nih.gov/pubmed/27885467 http://dx.doi.org/10.1007/s00520-016-3492-8 |
| _version_ | 1782488438987030528 |
|---|---|
| author | Stopeck, Alison T. Warner, Douglas J. |
| author_facet | Stopeck, Alison T. Warner, Douglas J. |
| author_sort | Stopeck, Alison T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5196008 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-51960082017-01-13 Response to letter to the Editors—Safety of long-term denosumab therapy Stopeck, Alison T. Warner, Douglas J. Support Care Cancer Letter to the Editor Springer Berlin Heidelberg 2016-11-24 2017 /pmc/articles/PMC5196008/ /pubmed/27885467 http://dx.doi.org/10.1007/s00520-016-3492-8 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Stopeck, Alison T. Warner, Douglas J. Response to letter to the Editors—Safety of long-term denosumab therapy |
| title | Response to letter to the Editors—Safety of long-term denosumab therapy |
| title_full | Response to letter to the Editors—Safety of long-term denosumab therapy |
| title_fullStr | Response to letter to the Editors—Safety of long-term denosumab therapy |
| title_full_unstemmed | Response to letter to the Editors—Safety of long-term denosumab therapy |
| title_short | Response to letter to the Editors—Safety of long-term denosumab therapy |
| title_sort | response to letter to the editors—safety of long-term denosumab therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196008/ https://www.ncbi.nlm.nih.gov/pubmed/27885467 http://dx.doi.org/10.1007/s00520-016-3492-8 |
| work_keys_str_mv | AT stopeckalisont responsetolettertotheeditorssafetyoflongtermdenosumabtherapy AT warnerdouglasj responsetolettertotheeditorssafetyoflongtermdenosumabtherapy |